$USNA

IIEKKING G DOUG sold $101K of USNA

IIEKKING G DOUG (CHIEF FINANCIAL OFFICER) sold 5,360 shares of USANA HEALTH SCIENCES INC (USNA) at $18.75 ($0.10M total) on 2026-05-27.

Original reporting
SEC EDGAR · IIEKKING G DOUG
Published May 28, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$USNA
Neutral
medium confidence
Mentioned
$USNA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$USNANeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale details (shares, price, total value, and post-sale holdings). There is no accompanying company news such as guidance, contracts, litigation, or regulatory action.

02

Market read

Traders may note insider selling, but the disclosure alone is unlikely to drive a sustained repricing without additional fundamental catalysts.

03

What to watch

The article does not specify whether other insiders sold/bought, whether the CFO had prior large holdings, or whether there were compensatory sales that could normalize insider activity.

Relevance 4/10Novelty 3/10Timing: filed 2026-05-28 after trade dated 2026-05-27

Background

The article is a SEC Form 4 insider transaction disclosure for USANA Health Sciences, reported by its CFO.

Company-level read

Ticker impact

$USNANeutralMedium confidence
Context

USANA CFO sold 5,360 shares in an open-market transaction for about $100.5K, leaving 0 shares after the trade.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction. The article provides trade size, price, and post-transaction holdings, but no earnings, guidance, or operational change.

Market effects

No clear sector read-through from a single, small CFO sale.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification, taxes, or planned liquidity needs, especially since the filing does not indicate any operational issue.

Key entities

  • USANA HEALTH SCIENCES INC

    Company whose CFO executed an open-market sale disclosed on Form 4.

  • IIEKKING G DOUG

    Chief Financial Officer who sold 5,360 shares at $18.7525 on 2026-05-27.

Related articles

$USNAHigh

USANA HEALTH SCIENCES INC (USNA): Results of Operations and Financial Condition

USANA HEALTH SCIENCES INC (USNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningsreleaseex991.htm EX-99.1 Document USANA Health Sciences Reports Second Quarter 2026 Results Company Continues Evolution to a Diversified, Omnichannel Health and Wellness Business SALT LAKE CITY, August 4, 2026 (BUSINESS WIRE)—USANA Health Sciences, Inc. (N